-
1
Unlocking methodological insights on oncology efficacy endpoints: from statistical to clinical and vice versa. Letter to the editor regarding ‘Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3’ by M. P. Goetz et al
Veröffentlicht in Annals of oncology
VolltextArtikel -
2
Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach
Veröffentlicht in Neurology
VolltextArtikel -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis
Veröffentlicht in Neurology
VolltextArtikel -
15
-
16
-
17
-
18
-
19
-
20